Sumatriptan nasal spray: A dose-ranging study in the acute treatment of migraine

European Journal of Neurology

Volumn 6, Issue 1, 1999, Pages 43-49

  Peikert, A ^a,e   Becker, W J ^f   Ashford, E A ^b   Dahlof, C ^c   Hassani, H ^b   Salonen, R J ^d  

^a Stadtirches Klin Sanatoriumsplatz 2   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Gothenburg Migraine Clinic   (Sweden)

^d Glaxo Wellcome Pharmaceutical Oy   (Finland)

^e Private Practice Neurology   (Germany)

^f NONE

Author keywords

Acute treatment of migraine; Dose ranging; Nasal spray; Placebo controlled; Sumatriptan

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN TINGLING; TASTE DISORDER; TREMOR; VOMITING;

EID: 0033037460     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.610043.x     Document Type: Article

References (10)

1. Cady RK, et al. (1991). Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265:2831-2835.
2. Cutler N, Mushet GR, Davis R, Clements B, Whitcher L (1995). Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths. Neurology 45(suppl 7):5-9.
3. Headache Classification Committee of the International Headache Society (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalgia 8(suppl 7):1-96.
4. Moore KHP, Hussey EK, Shaw S, Fuseau E, Duquesnoy C, Pakes GE (1997). Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Cephalgia 17:541-550.
5. Pfaffenrath V, Cunin G, Sjonell G, Prendergast S (1998). Efficacy and safety of sumatriptan tablets in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache 38:184-190.
6. Salonen R, et al. for the International Intranasal Study Group (1994). Sumatriptan nasal spray for the acute treatment of migraine. J Neurol 241:463-469.
7. Sargent J, Kirchner JR, Davis R, Kirkhart B (1995). Oral sumatriptan is effective and well tolerated for the acute treatment of migraine. Neurology 45(suppl 7):S10-S14.
8. The Finnish Sumatriptan Group (1991). A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur Neurol 31:332-338.
9. The Oral Sumatriptan Dose-defining Study Group (1991). Sumatriptan - An oral dose-defining study. Eur Neurol 31:300-305.
10. The Subcutaneous Sumatriptan International Study Group (1991). Treatment of migraine attacks with sumatriptan. N Engl J Med 325:316-321.